TROCOXIL 75 MG CHEWABLE TABLETS VETERINARY

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

MAVACOXIB

متاح من:

ZOETIS ISRAEL HOLDING B.V., ISRAEL

الشكل الصيدلاني:

CHEWABLE TABLETS

تركيب:

MAVACOXIB 75 MG

طريقة التعاطي:

PER OS

نوع الوصفة الطبية :

Required

المصنعة من قبل:

PFIZER ITALIA S.R.L., ITALY

الخصائص العلاجية:

For the treatment of pain and inflammation associated with degenerative joint disease in dogs in cases where continuous treatment exceeding one month is indicated

تاريخ الترخيص:

2018-06-30

نشرة المعلومات

VETERINARY MEDICINE PACKAGE LEAFLET
This medicine is dispensed with a veterinarian’s prescription only
For use in animals only
1. NAME, FORM AND STRENGTH OF THE VETERINARY MEDICINE:
Trocoxil 20 mg Chewable Tablets Veterinary
Trocoxil 30 mg Chewable Tablets Veterinary
Trocoxil 75 mg Chewable Tablets Veterinary
Trocoxil 95 mg Chewable Tablets Veterinary
2. ACTIVE INGREDIENT
Each tablet of Trocoxil Veterinary 20 mg contains mavacoxib 20 mg
Each tablet of Trocoxil Veterinary 30 mg contains mavacoxib 30 mg
Each tablet of Trocoxil Veterinary 75 mg contains mavacoxib 75 mg
Each tablet of Trocoxil Veterinary 95 mg contains mavacoxib 95 mg
List of the inactive ingredients in section 13.
3. WHAT IS THIS MEDICINE INTENDED FOR?
For the treatment of pain and inflammation associated with
degenerative joint disease in dogs in cases
where continuous treatment exceeding one month is indicated.
Trocoxil veterinary belongs to a group of medicines called
Non-Steroidal Anti-Inflammatory Drugs
(NSAIDs) which are used to treat pain and inflammation.
4. CONTRAINDICATIONS
Do not use in dogs less than 12 months of age and/or that weigh less
than 7 kg.
Do not use in dogs suffering from gastro-intestinal problems,
including ulceration and bleeding.
Do not use where there is evidence of bleeding.
Do not use when there is impaired kidney or liver function.
Do not use in cases of heart insufficiency.
Do not use in pregnant, breeding or lactating animals.
Do not use if there is known hypersensitivity to the active substance
or to any of the excipients.
Do not use in case of known hypersensitivity to sulphonamides.
Do not use concomitantly with glucocorticoids or other NSAIDs.
Avoid use in dehydrated, hypovolaemic or hypotensive animals, as there
is a potential risk of increased
renal toxicity.
5. ADVERSE REACTIONS
Adverse reactions of the digestive tract such as vomiting and
diarrhoea were commonly reported, loss
of appetite, haemorrhagic diarrhoea and melaena have been reported in
uncommon cases.
Gastrointestinal ulceration was reported in r